Hepatobiliary Associates of New York

Bayside, New York 11358

0 studies enrolling now · 3 studies all time

What they study most

Compensated Chronic Hepatitis B, Crohn's Disease, Ulcerative Colitis

Studies at this site

• Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks — Withdrawn before enrolling
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease — Completed
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis — Completed